Simple jQuery Dropdowns
Please use this identifier to cite or link to this item:
Title: Curdlan sulphate in human severe/cerebral Plasmodium falciparum malaria
Authors: I. Havlik
S. Looareesuwan
S. Vannaphan
P. Wilairatana
S. Krudsood
P. E. Thuma
D. Kozbor
N. Watanabe
Y. Kaneko
University of Witwatersrand
Mahidol University
Macha Malaria Research Institute
Roswell Park Cancer Institute
Jikei University School of Medicine
Ajinomoto Co Inc
Kindai University
Keywords: Immunology and Microbiology;Medicine
Issue Date: 1-May-2005
Citation: Transactions of the Royal Society of Tropical Medicine and Hygiene. Vol.99, No.5 (2005), 333-340
Abstract: Preclinical studies have shown that curdlan sulphate (CRDS), a sulphated 1 → 3-β-D glucan, inhibits Plasmodium falciparum in vitro and down-modulates the immune response. A direct, non-specific effect on cytoadherence and rosetting may be predicted, as has been described with other sulphated polysaccharides, e.g. heparin. The anticoagulant effect of CRDS is 10-fold lower than heparin. Curdlan sulphate has, therefore, emerged as a candidate for adjunct medication in the treatment of severe/ cerebral malaria. Two clinical studies were conducted using CRDS as adjunct medication to conventional therapy (artesunate) in patients with severe and severe/cerebral malaria. Both studies were double-blind and placebo-controlled to evaluate the efficacy and safety of the combination. Curdlan sulphate appeared to reduce the severity of the disease process, e.g. fever clearance time was shortened. Due to the small number of patients, there was no difference in mortality. The two treatment arms in both studies showed similar results for all laboratory parameters. The only adverse event recorded during CRDS treatment was an increase in activated partial thromboplastin time. This can be monitored easily. It seems that the patients who may benefit most are severe/ cerebral cases with no organ damage on admission. © 2004 Royal Society of Tropical Medicine Hygiene. Published by Elsevier Ltd. All rights reserved.
ISSN: 00359203
Appears in Collections:Scopus 2001-2005

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.